Martin Lapel

Martin Lapel is a seasoned regulatory affairs professional with significant experience in the biopharmaceutical sector. Currently serving as the Regulatory Affairs Manager at coIMMUNE, Inc. since November 2022, Martin previously held roles at Atara Biotherapeutics from February 2017 to August 2022, progressing from Regulatory Affairs Specialist to Project Manager. Martin has demonstrated expertise in maintaining global regulatory strategies, facilitating regulatory meetings, and coordinating cross-functional teams for CAR-T programs. Earlier experience includes a series of research positions at the University of Colorado Denver, where responsibilities encompassed tissue culture, project management, and training of post-baccalaureate students, coupled with a strong foundation in molecular biology techniques. Martin holds a Bachelor of Science degree with dual majors in Biology and Chemistry from Metropolitan State University of Denver.